AFC-HD AMS Life Science Co., Ltd.

TSE:2927 Stock Report

Market Cap: JP¥12.4b

AFC-HD AMS Life Science Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure22.3yrs
Board average tenure4.2yrs

Recent management updates

Recent updates

AFC-HD AMS Life Science (TSE:2927) Is Paying Out A Larger Dividend Than Last Year

Jan 09
AFC-HD AMS Life Science (TSE:2927) Is Paying Out A Larger Dividend Than Last Year

AFC-HD AMS Life Science's (TSE:2927) Dividend Will Be Increased To ¥16.00

Dec 19
AFC-HD AMS Life Science's (TSE:2927) Dividend Will Be Increased To ¥16.00

AFC-HD AMS Life Science (TSE:2927) Is Due To Pay A Dividend Of ¥15.00

Apr 17
AFC-HD AMS Life Science (TSE:2927) Is Due To Pay A Dividend Of ¥15.00

Here's Why I Think AFC-HD AMS Life Science (TYO:2927) Might Deserve Your Attention Today

Apr 29
Here's Why I Think AFC-HD AMS Life Science (TYO:2927) Might Deserve Your Attention Today

These 4 Measures Indicate That AFC-HD AMS Life Science (TYO:2927) Is Using Debt Safely

Apr 14
These 4 Measures Indicate That AFC-HD AMS Life Science (TYO:2927) Is Using Debt Safely

AFC-HD AMS Life Science Co., Ltd.'s (TYO:2927) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Mar 09
AFC-HD AMS Life Science Co., Ltd.'s (TYO:2927) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Is It Smart To Buy AFC-HD AMS Life Science Co., Ltd. (TYO:2927) Before It Goes Ex-Dividend?

Feb 20
Is It Smart To Buy AFC-HD AMS Life Science Co., Ltd. (TYO:2927) Before It Goes Ex-Dividend?

The Trends At AFC-HD AMS Life Science (TYO:2927) That You Should Know About

Feb 04
The Trends At AFC-HD AMS Life Science (TYO:2927) That You Should Know About

Here's Why I Think AFC-HD AMS Life Science (TYO:2927) Is An Interesting Stock

Jan 17
Here's Why I Think AFC-HD AMS Life Science (TYO:2927) Is An Interesting Stock

These 4 Measures Indicate That AFC-HD AMS Life Science (TYO:2927) Is Using Debt Reasonably Well

Dec 29
These 4 Measures Indicate That AFC-HD AMS Life Science (TYO:2927) Is Using Debt Reasonably Well

AFC-HD AMS Life Science Co., Ltd. (TYO:2927) On An Uptrend: Could Fundamentals Be Driving The Stock?

Dec 02
AFC-HD AMS Life Science Co., Ltd. (TYO:2927) On An Uptrend: Could Fundamentals Be Driving The Stock?

CEO

AFC-HD AMS Life Science has no CEO, or we have no data on them.


Leadership Team

NamePositionTenureCompensationOwnership
Nobue Hamabe
Accounting Manager & Director22.3yrsno data0.17%
¥ 21.3m
Naoya Unno
GM of Technical Development Division & Director22.3yrsno data0.23%
¥ 29.1m
Shigenori Fukuchi
Senior MD19.2yrsno data0.29%
¥ 36.2m

22.3yrs

Average Tenure

55yo

Average Age

Experienced Management: 2927's management team is seasoned and experienced (22.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Nobue Hamabe
Accounting Manager & Director2.2yrsno data0.17%
¥ 21.3m
Naoya Unno
GM of Technical Development Division & Director21.3yrsno data0.23%
¥ 29.1m
Shigenori Fukuchi
Senior MD21.3yrsno data0.29%
¥ 36.2m
Takehiko Asayama
Chairman23.5yrsJP¥234.60m8.4%
¥ 1.0b
Hiroshi Unno
Independent Outside Director4.2yrsno data0.022%
¥ 2.7m
Shigeo Minakata
Director3.2yrsno data0.055%
¥ 6.8m
Shunji Sasahara
Director4.2yrsno data0.050%
¥ 6.2m

4.2yrs

Average Tenure

55yo

Average Age

Experienced Board: 2927's board of directors are considered experienced (4.2 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/23 18:02
End of Day Share Price 2025/01/23 00:00
Earnings2024/11/30
Annual Earnings2024/08/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

AFC-HD AMS Life Science Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution